Lantheus To Present At The Morgan Stanley 23Rd Annual Global Healthcare Conference

(MENAFN- GlobeNewsWire - Nasdaq) BEDFORD, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 23^rd Annual Global Healthcare Conference at 7:00 a.m. ET on Tuesday, September 9.

To access the live webcast of the presentation, please visit the Investors section of the Company's website at . A replay of the webcast will be available on the Company's website for at least 30 days following the live presentation.

About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden and Switzerland, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit .

Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
...

Melissa Downs
Executive Director, External Communications
646-975-2533
...

MENAFN02092025004107003653ID1110005839